Common Anti-Inflammatory Drug Shows Promise in Slowing Blood Cell Mutation Linked to Cardiovascular Disease Risk
A groundbreaking subanalysis of the LoDoCo2 trial unveiled compelling evidence that daily administration of low-dose colchicine may decelerate the expansion ...
